Skip to content

Washington University, Saint Louis University Receive $6.4 Million in Funding for Opioid-Related Research Through Blunt-Backed NIH Program

September 27, 2019

WASHINGTON – U.S. Senator Roy Blunt (Mo.), Chairman of the Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies (Labor/HHS), today commended the National Institutes of Health (NIH) announcement that it awarded Missouri $6.4 million in funding for opioid-related research. The funding, which was included in the Blunt-backed FY2018 and FY2019 Labor/HHS appropriations bills, was awarded to Washington University and Saint Louis University.

“Prioritizing resources for opioid-related research is key to gaining a better understanding of how we can more effectively combat this epidemic,” said Blunt. “These resources will support initiatives focused on improving treatment services, preventing addiction in the first place, and developing new non-addictive treatments for pain management. I’ll keep working to ensure the NIH and medical professionals have the tools they need to continue playing an important role in ending this public health crisis.”

Blunt prioritized a total of $3.8 billion for opioid programs in the FY2019 Labor/HHS appropriations bill, and $500 million specifically for NIH research. Under Blunt’s chairmanship, funding for opioid-related Labor/HHS programs has increased by more than $3.5 billion over four years. 

Following are details from the announcement:

Recipient
Amount
Research Focus Area
Washington University
$265,360

Enhanced outcomes for infants and children exposed to opioids

Washington University
$2,096,911

Novel medication options for opioid use disorder

Washington University
$1,218,127

Preclinical and translational research in pain management

Washington University
$637,127

New strategies to prevent and treat opioid addiction

Saint Louis University
$2,156,764

Preclinical and translational research in pain management


Next Article » « Previous Article